amendment_0002_v2.pdf
PDF 327 KB Posted
- Attached to
- Olanzapine
- Solicitation number
- spe2d2-19-r-0042
About this file
Amendment 0002
View the file
Other files
Show all 12
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
X
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE 1 OF 3
2. AMENDMENT/MODIFICATION NO.
3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQ. NO.
See Block 14
5. PROJECT NO. (If applicable)
6. ISSUED BY CODE SPE2D2 7. ADMINISTERED BY (If other than Item 6) CODE
DLA TROOP SUPPORT
MEDICAL SUPPLY CHAIN FSGB
700 ROBBINS AVENUE
PHILADELPHIA PA 19111
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code) (X) 9A. AMENDMENT OF SOLICITATION NO.
SPE2D219R0042
9B. DATED (SEE ITEM 11)
2019 APR 30
10A. MODIFICATION OF CONTRACT/ORDER NO.
10B. DATED (SEE ITEM 13)
CODE FACILITY CODE
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended, is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
(a) By completing Items 8 and 15, and returning 3 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;
or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
12. ACCOUNTING AND APPROPRIATION DATA (If required)
13. THIS APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.
IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO.
IN ITEM 10A.
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc. ) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
D. OTHER (Specify type of modification and authority)
E. IMPORTANT: Contractor is not, is required to sign this document and return copies to issuing office.
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
Opening/Closing Date Changed to:
2019 APR 30 / 2019 JUN 13
TIME 3:00 PM
See Attached Continuation Sheet(s).
Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15A NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
15B. CONTRACTOR/OFFEROR
(Signature of person authorized to sign)
15C. DATE SIGNED 16B. UNITED STATES OF AMERICA
(Signature of Contracting Officer)
16C. DATE SIGNED
NSN 7540-01-152-8070
Previous edition unusable
STANDARD FORM 30 (REV. 10-83)
Prescribed by GSA FAR (48 CFR) 53.243
CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: PAGE 2 OF 3 PAGES
SPE2D219R0042 - 0002
1. The closing date of the solicitation has been extended to 06/13/2019 03:00PM EST.
2. Line item 0017 Olanzapine 10MG 1 count vials have been removed from the solicitation.
3. Pages 2-4, 43-44, 49, 75-82 have been updated accordingly. See attached.
4. All other terms and conditions remain unchanged.
CONTINUED ON NEXT PAGE
CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: PAGE 3 OF 3 PAGES
SPE2D219R0042 - 0002
Attachments
List of Attachments
File Name Description ATTACH_backup amendment 0002 backup.
The following pages have been updated to reflect the changes:
Pages 2-4
ITEM NO.
20.
SCHEDULE OF SUPPLIES/SERVICES
21.
QUANTIT
Y
22.
UNIT
23.
UNIT
PRICE
24.
AMOUNT
0001AA
0001AB
0001AC
0001AD
0001AE
0002AA
0002AB
0002AC
0002AD
0002AE
0003AA
0003AB
0003AC
0003AD
0003AE
0004AA
0004AB
0004AC
0004AD
0004AE
0005AA
0005AB
0005AC
0005AD
0005AE
0006AA
0006AB
0006AC
0006AD
0006AE
0007AA
0007AB
0007AC
0007AD
0007AE
Olanzapine 2.5MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 2.5MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 5MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 5MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 7.5MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 7.5MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 10MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
5,951
5,951
17,522
17,522
19,574
19,574
22,943
22,943
30,004
30,004
13,100
13,100
**BT
BT
BT
BT
BT
BT
BT
BT
BT
0008AA
0008AB
0008AC
0008AD
0008AE
0009AA
0009AB
0009AC
0009AD
0009AE
0010AA
0010AB
0010AC
0010AD
0010AE
0011AA
0011AB
0011AC
0011AD
0011AE
0012AA
0012AB
0012AC
0012AD
0012AE
0013AA
0013AB
0013AC
0013AD
0013AE
0014AA
0014AB
0014AC
0014AD
0014AE
0015AA
0015AB
0015AC
Olanzapine 10MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 15MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 15MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 20MG 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 20MG 1000 count bottle National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 5MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2
Olanzapine 10MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4
Olanzapine 15MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2
4,530
4,530
3,775
3,775
1,349
1,349
11,668
11,668
3,633
3,633
3,601
3,601
1,437
BT
BT
BT
BT
BT
BT
BT
Page 43-44
Tab A: Offeror's Proposed Price Offerors are required to provide pricing information for line items 0001- 0016. For CLIN 0001 offers shall include pricing for 5,951 2.5MG 30 count bottles. For CLIN 0002 offers shall include pricing for 17,522 2.5MG 1000 count bottles. For CLIN 0003 offers shall include pricing for 19,574 5MG 30 count bottles. For CLIN 0004 offers shall include pricing for 22,943 5MG 1000 count bottles. For CLIN 0005 offers shall include pricing for 30,004 7.5MG 30 count bottles. For CLIN 0006 offers shall include pricing for 108 7.5MG 1000 count bottles. For CLIN 0007 offers shall include pricing for 13,100 10MG 30 count bottles. For CLIN 0008 offers shall include pricing for 4,530 10MG 1000 count bottles. For CLIN 0009 offers shall include pricing for 3,775 15MG 30 count bottles. For CLIN 0010 offers shall include pricing for 1,349 15MG 1000 count bottles. For CLIN 0011 offers shall include pricing for 11,668 20MG 30 count bottles. For CLIN 0012 offers shall include pricing for 448 20MG 1000 count bottles. For CLIN 0013 offers shall include pricing for 3,633 5MG 30 count bottles (rapids). For CLIN 0014 offers shall include pricing for 3,601 10MG 30 count bottles (rapids). For CLIN 0015 offers shall include pricing for 1,437 15MG 30 count bottles (rapids). For CLIN 0016 offers shall include pricing for 1,078 20MG 30 count bottles (rapids). The offeror’s proposed prices are to be expressed in dollars as a unit price per bottle.
The offeror is required to submit its offered prices for each line item for the base and all option years as stated above as part of the offeror’s price proposal. The reverse auction process, telephonic negotiations and/or email negotiations may be used to determine the lowest price evaluated (unit price per bottle).
Extraneous Data: Offerors are not to include extraneous data such as, annual reports, marketing brochures, catalogs, etc.
In conducting the evaluation, the Defense Logistics Agency (DLA) will use information provided by the offeror in the proposal. The burden is on the offeror to provide a complete and thorough proposal. Proposals that are missing information or components identified above will be considered incomplete and may be eliminated from further consideration of award.
FAR 52.212-1 Addendum 3 -- Volume 2 - Price Proposal
0015AD
0015AE
0016AA
0016AB
0016AC
0016AD
0016AE
Olanzapine 20MG Rapids 30 count bottle* National Drug Code (NDC) ____-___-__ Base Year Option Year 1 Option Year 2
*Package size is unit of use and is subject to Statement of Work - “Preparation for Delivery” requirement.
** BT = Bottle
-The quantities specified in the Schedule are estimates only.
Reference FAR 52.216-21 Requirements for additional details.
1,078
1,078
BT
Organization of Offered Prices: Offerors are required to provide the following mandatory pricing information, expressed in dollars as a unit price per bottle, for line items 0001 through 0016:
The offeror is required to submit offered prices for each line item for the base and all option years as stated above as part of the offeror’s price proposal. The reverse auction process, telephonic negotiations and/or email negotiations may be used to determine the lowest price.
i. Lowest Evaluated Price.
After overall acceptable offers are identified; telephonic negotiations, email negotiations and/or reverse auction may be conducted for all offers in the competitive range. Offerors will be able to submit revised prices during discussions and the reverse auction process, if discussions and/or reverse auction processes are held.
Offerors are required to provide pricing information for line items 0001 through 0016. The offeror’s proposed prices are to be expressed in dollars as a unit price per bottle.
The offeror is required to submit its offered prices for each line item for the base and all option years as stated above as part of the offeror’s price proposal. The reverse auction process, telephonic negotiations and/or email negotiations may be used to determine the lowest price evaluated (unit price per bottle).
The overall lowest evaluated aggregate price will be determined by multiplying the estimated quantity for each line item, including options, by the offered unit price and then adding the total of each line.
Page 75 – the text below has been removed from the solicitation
LINE ITEM 0017: OLANZAPINE 10MG 1 COUNT VIAL
All prices exclusive of Federal Excise Tax:
Current (2019) Commercial List Price: ___________
Previous (2018) Commercial List Price: ___________
2019 Federal Supply Schedule Price: ___________
2018 Federal Supply Schedule Price: ___________
2019 Federal Ceiling Price ___________
2018 Federal Ceiling Price ___________
Pages 76-82 have been updated to the following:
TABLETS, CAPSULES AND PILLS
Item Complete Address of Facility Where Ingredients are Measured, Weighed, Mixed and Compounded
Point of Contact Including Phone Number
0001 – Olanzapine 2.5MG 30 count bottle
0002 – Olanzapine 2.5MG 1000 count bottle
0003 – Olanzapine 5MG
0004 – Olanzapine 5MG
0005 – Olanzapine 7.5MG
0006 – Olanzapine 7.5MG
0007 – Olanzapine 10MG
0008 – Olanzapine 10MG
0009 – Olanzapine 15MG
0010 – Olanzapine 15MG
0011 – Olanzapine 20MG
0012 – Olanzapine 20MG
0013 – Olanzapine 5MG rapids
0014 – Olanzapine 10MG rapids
0015 – Olanzapine 15MG rapids
0016 – Olanzapine 20MG rapids
PACKAGING
Item Complete Address of Facilities
Where Intermediate Containers will be Filled and Labeled
Point of Contact Including Phone Number
PACKING
Item Complete Address of Facilities
Where Products will be Packed and Prepared for Shipment
Point of Contact Including Phone Number
| 11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS |
| 13. THIS APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS. |
| CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: PAGE 2 OF 3 PAGES SPE2D219R0042 - 0002 |
File details come from the government source that posted it.